本页面由Tiger Trade Technology Pte. Ltd.提供服务

Aptevo Therapeutics Inc.

1.84
+0.04632.59%
盘后:1.840.0037+0.20%19:41 EDT
成交量:28.64万
成交额:53.03万
市值:330.90万
市盈率:-0.03
高:1.97
开:1.79
低:1.76
收:1.79
52周最高:31.14
52周最低:1.37
股本:180.20万
流通股本:170.46万
量比:13.07
换手率:16.80%
股息:- -
股息率:- -
每股收益(TTM):-58.0829
每股收益(LYR):-82.2951
净资产收益率:-420.34%
总资产收益率:-111.49%
市净率:0.55
市盈率(LYR):-0.02

数据加载中...

公司资料

公司名字:
Aptevo Therapeutics Inc.
交易所:
NASDAQ
成立时间:
2016
员工人数:
33
公司地址:
2401 4th Avenue,Suite 1050,Seattle,Washington,United States
邮编:
98121
电话:
传真:
206 838 0503
简介:
Aptevo Therapeutics Inc.于2016年2月在特拉华州注册成立。该公司是一家临床阶段的研发生物技术公司,专注于开发用于治疗不同形式癌症的新型免疫疗法候选者。该公司开发了两种多功能平台技术,用于合理设计精准免疫调节药物。

董事

名称
职位
Jeffrey G. Lamothe
Chief Executive Officer,Director and President
Barbara Lopez Kunz
Independent Director
Daniel J. Abdun Nabi
Independent Director
Grady Grant, III
Independent Director
John E. Niederhuber
Lead Independent Director
Marvin L. White
Director and Executive Chair
Zsolt Harsanyi
Independent Director

股东

名称
职位
Jeffrey G. Lamothe
Chief Executive Officer,Director and President
Daphne Taylor
Chief Financial Officer and Senior Vice President
Dirk Huebner
Chief Medical Officer and Senior Vice President
Mary Janatpour
Chief Scientific Officer and Senior Vice President
SoYoung Kwon
General Counsel, Business Development and Corporate Affairs and Senior Vice President
Marvin L. White
Director and Executive Chair